- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07607379
Robotic Dog Intervention on Emotional Well-Being and Quality of Life (ROBDOG)
Effectiveness and Feasibility of a Robotic Dog Intervention on Emotional Well-Being and Quality of Life in Pediatric Patients With Hematological Malignancies Undergoing HSCT
Обзор исследования
Статус
Вмешательство/лечение
Подробное описание
Pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) experience substantial psychological burden related to intensive treatment, protective isolation, prolonged hospitalization, and immunosuppression. Anxiety, emotional distress, loneliness, and reduced quality of life are common during the post-transplant inpatient period. However, infection control precautions and isolation procedures may limit access to traditional psychosocial support interventions in HSCT settings.
Technology-assisted interventions, particularly social robots, have emerged as promising approaches for supporting emotional well-being in pediatric healthcare environments. AI-powered robotic companion devices may provide interactive engagement, emotional comfort, and opportunities for play during prolonged hospitalization while remaining compatible with infection control requirements.
This pilot randomized controlled study aims to evaluate the effectiveness, feasibility, and acceptability of an AI-powered robotic dog intervention in improving emotional well-being and quality of life in pediatric patients undergoing HSCT.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Eysan Savaş, PhD
- Номер телефона: +90 5068418841
- Электронная почта: eysansavas@gmail.com
Учебное резервное копирование контактов
- Имя: Remziye Semerci, PhD
- Номер телефона: +90 535 0112821
- Электронная почта: remziyesemerci@gmail.com
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
Принимает здоровых добровольцев
Описание
Inclusion Criteria:
- Pediatric patients aged 8-15 years
- Diagnosed with a hematological malignancy and undergoing hematopoietic stem cell transplantation
- Hospitalized in a protective isolation room during the post-transplant inpatient period
- Expected to remain hospitalized under isolation for approximately 30 days post-transplant
- Able to understand and respond to Turkish-language self-report questionnaires
- Clinically stable and deemed eligible for participation by the treating clinical team
- Able to interact with the robotic dog at a basic functional level
Exclusion Criteria:
- Severe cognitive impairment or neurodevelopmental conditions preventing meaningful interaction or self-report
- Acute neurological conditions, delirium, or severe psychiatric crisis (e.g., acute agitation, suicidal ideation)
- Requirement for intensive care, invasive ventilation, or a clinically unstable condition
- Severe visual, hearing, or motor impairments that prevent interaction with the robotic dog
- Additional infection control restrictions prevent the placement or use of the robotic dog in the isolation room
- Anticipated early discharge, transfer, or inability to complete follow-up assessments
- Severe fear, intolerance, or refusal to interact with robotic or electronic devices
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Без вмешательства: Standard care & Control Group Care
Participants in the control group will receive standard post-transplant inpatient care routinely provided in the HSCT unit.
Standard care includes protective isolation procedures, restricted visitor access, routine clinical monitoring, and infection control practices during the inpatient transplantation period.
Children are permitted to use personal electronic devices and other approved washable or disinfectable materials available within institutional infection control regulations.
No structured psychosocial or technology-assisted intervention will be provided to the control group during the study period.
|
|
|
Экспериментальный: Intervention Group (AIBO Group):
Participants assigned to the intervention group will receive standard post-transplant inpatient care in addition to a technology-assisted psychosocial support intervention during the inpatient isolation period following HSCT.
The intervention will be implemented throughout the hospitalization period, and participants will be encouraged to engage with the device regularly during daily care routines.
Baseline assessments will be performed within the first 24-48 hours after HSCT, and follow-up assessments will be conducted weekly for four weeks.
Intervention adherence, feasibility indicators, and adverse events will be monitored throughout the study period.
Infection control procedures will be applied according to institutional protocols.
|
AIBO is an AI-powered interactive robot dog that engages children through play and touch-based interactions, including responding to petting, interacting with a ball, and making simple gestures.
Using visual, auditory, and tactile sensing, AIBO enables spontaneous, child-centered interactions, expressing emotions through eye color changes, tail movements, and vocalizations, while gradually developing more adaptive behaviors through repeated interactions (weight: ~2.2 kg; dimensions: 180 × 293 × 305 mm)
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change in Positive and Negative Affect
Временное ограничение: Baseline (Day 1, before intervention initiation) and weekly assessments during the intervention period at Weeks 2, 3, and 4.
|
Emotional affect will be assessed using the Positive and Negative Affect Schedule for Children (PANAS-C).
The scale evaluates positive and negative emotional states experienced by pediatric patients undergoing hematopoietic stem cell transplantation during the inpatient isolation period.
|
Baseline (Day 1, before intervention initiation) and weekly assessments during the intervention period at Weeks 2, 3, and 4.
|
|
Change in Emotional Well-being
Временное ограничение: Baseline (Day 1, before intervention initiation) and weekly assessments during the intervention period at Weeks 2, 3, and 4.
|
Children's emotional well-being will be assessed using the Stirling Children's Well-being Scale.
The scale evaluates positive emotional functioning, interpersonal relationships, and overall psychological well-being in children undergoing hematopoietic stem cell transplantation during the inpatient isolation period.
|
Baseline (Day 1, before intervention initiation) and weekly assessments during the intervention period at Weeks 2, 3, and 4.
|
|
Change in Health-Related Quality of Life
Временное ограничение: Baseline (Day 1, prior to intervention initiation) and Week 4 (post-intervention assessment after completion of the 4-week intervention period).
|
Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL 4.0).
The scale consists of 23 items evaluating physical, emotional, social, and school functioning in children and adolescents.
Items are rated on a 5-point Likert scale, with higher scores indicating better health-related quality of life.
|
Baseline (Day 1, prior to intervention initiation) and Week 4 (post-intervention assessment after completion of the 4-week intervention period).
|
Соавторы и исследователи
Спонсор
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- KOCUNIVR
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .